← Open Payments lookup

CATHERINE LASPERCHES: Open Payments

NPI 1205857224 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$806 in 7 payments from 7 companies in 2025. Trend: 2023 $623 · 2024 $636 · 2025 $806

Food & beverage: $806
CompanyPaymentsAmount
Dexcom, Inc.1$163
Bayer Healthcare Pharmaceuticals Inc.1$140
Janssen Biotech, Inc.1$137
Madrigal Pharmaceuticals1$123
Teva Pharmaceuticals USA, Inc.1$117
GENZYME CORPORATION1$110
ABBVIE INC.1$15

Products named: DEXCOM G7 GSS (161), Kerendia, REZDIFFRA, UZEDY, DUPIXENT, UBRELVY.

Industry payments across LA — which companies pay providers there.